Clinical Trial Update: A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating OZURDEX for macular edema due to branch retinal vein occlusion, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Allergan | Conditions: Macular Edema, Retinal Vein Occlusion | Phase 4 | Status: COMPLETED | Results posted: 2016-07-21